Matches in Wikidata for { <http://www.wikidata.org/entity/Q94914216> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q94914216 description "article scientifique publié en 2020" @default.
- Q94914216 description "artykuł naukowy opublikowany 14 maja 2020" @default.
- Q94914216 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94914216 description "scientific article published on 14 May 2020" @default.
- Q94914216 description "wetenschappelijk artikel" @default.
- Q94914216 description "наукова стаття, опублікована 14 травня 2020" @default.
- Q94914216 name "Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma" @default.
- Q94914216 name "Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma" @default.
- Q94914216 type Item @default.
- Q94914216 label "Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma" @default.
- Q94914216 label "Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma" @default.
- Q94914216 prefLabel "Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma" @default.
- Q94914216 prefLabel "Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma" @default.
- Q94914216 P1433 Q94914216-99834E0A-7A63-4E52-87D4-E1A09C69B2B8 @default.
- Q94914216 P1476 Q94914216-A10D9FAE-BA53-4AC5-9241-2100F9B3266F @default.
- Q94914216 P2093 Q94914216-44383B6A-D959-47D3-B79C-5B29CAE8E5D3 @default.
- Q94914216 P2093 Q94914216-56BA285D-1564-42F8-A4B9-997C0D7F1A6E @default.
- Q94914216 P2093 Q94914216-698FFA76-0D07-4DCC-8C42-4EB02DF069A0 @default.
- Q94914216 P2093 Q94914216-6ED432CE-8D19-4488-922A-4BE465EC2466 @default.
- Q94914216 P2093 Q94914216-70197B56-6D2F-494F-8EA7-9FD025A06337 @default.
- Q94914216 P2093 Q94914216-93205F01-DD84-4020-BBE5-B14B853D5AD0 @default.
- Q94914216 P2093 Q94914216-A2E79BFF-3AD1-4C20-8FA2-D46A30F56C96 @default.
- Q94914216 P2093 Q94914216-C8DB7929-251F-4783-BB3E-0FA21FDF051B @default.
- Q94914216 P2093 Q94914216-CF84E19D-03F4-4FA8-A9E4-41BC303E6547 @default.
- Q94914216 P2093 Q94914216-D10855C0-33BE-48EB-A886-E2C8773F4B06 @default.
- Q94914216 P2093 Q94914216-F06A3D1B-D254-4696-AACE-F6B593288957 @default.
- Q94914216 P31 Q94914216-359CB6B1-3A08-42E4-AB3E-9DD60B7EB037 @default.
- Q94914216 P356 Q94914216-A8E4B9F0-FC22-482A-97A9-5D470564B869 @default.
- Q94914216 P50 Q94914216-18F31524-DB38-44A5-B49D-04F711B5ED6F @default.
- Q94914216 P50 Q94914216-9179DA39-33A2-4401-A9DF-A52075AC4773 @default.
- Q94914216 P577 Q94914216-E4E8B038-68CF-43E3-831A-93139C276AD8 @default.
- Q94914216 P698 Q94914216-F929C1A8-EC20-4D50-AF78-EA2D39BCD4D2 @default.
- Q94914216 P921 Q94914216-04B747D9-1260-4C61-9EB2-6C080AD1818B @default.
- Q94914216 P921 Q94914216-72EFBC42-C3F0-4192-B7D5-244D69316660 @default.
- Q94914216 P921 Q94914216-7FDB3DA0-B415-4734-90F1-9A8AC19FCE27 @default.
- Q94914216 P921 Q94914216-D1108A5C-D0E3-447B-A46E-B22B1941A285 @default.
- Q94914216 P921 Q94914216-E7DFE753-AEC3-490E-AB7C-4AD1943B36E4 @default.
- Q94914216 P356 BJH.16714 @default.
- Q94914216 P698 32410259 @default.
- Q94914216 P1433 Q4970200 @default.
- Q94914216 P1476 "Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma" @default.
- Q94914216 P2093 "Caterina Stelitano" @default.
- Q94914216 P2093 "Cristina Tecchio" @default.
- Q94914216 P2093 "Francesco Angrilli" @default.
- Q94914216 P2093 "Francesco Merli" @default.
- Q94914216 P2093 "Fulvio Massaro" @default.
- Q94914216 P2093 "Luigi Marcheselli" @default.
- Q94914216 P2093 "Mario Petrini" @default.
- Q94914216 P2093 "Massimo Federico" @default.
- Q94914216 P2093 "Sara Galimberti" @default.
- Q94914216 P2093 "Stefano Luminari" @default.
- Q94914216 P2093 "Yana Stepanishyna" @default.
- Q94914216 P31 Q13442814 @default.
- Q94914216 P356 "10.1111/BJH.16714" @default.
- Q94914216 P50 Q88291963 @default.
- Q94914216 P50 Q94914214 @default.
- Q94914216 P577 "2020-05-14T00:00:00Z" @default.
- Q94914216 P698 "32410259" @default.
- Q94914216 P921 Q180983 @default.
- Q94914216 P921 Q268713 @default.
- Q94914216 P921 Q412323 @default.
- Q94914216 P921 Q422232 @default.
- Q94914216 P921 Q42824440 @default.